0001415889-21-003112.txt : 20210621 0001415889-21-003112.hdr.sgml : 20210621 20210621161031 ACCESSION NUMBER: 0001415889-21-003112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210618 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOLAND DANIEL B CENTRAL INDEX KEY: 0001318485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 211030620 MAIL ADDRESS: STREET 1: 4560 HORTON STREET,M/S R-422 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 form4-06212021_040601.xml X0306 4 2021-06-18 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001318485 SOLAND DANIEL B C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BOULEVARD, SUITE 212 EXTON PA 19341 false true false false CHIEF OPERATING OFFICER Common Stock 2021-06-18 4 P 0 50000 1.19 A 78843 D /s/ Daniel B. Soland 2021-06-21